Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Total 13F shares
-
61,928,932
-
Share change
-
+3,592,875
-
Total reported value
-
$7,267,064,424
-
Put/Call ratio
-
66%
-
Price per share
-
$117.36
-
Number of holders
-
169
-
Value change
-
+$416,027,513
-
Number of buys
-
88
-
Number of sells
-
78
Institutional Holders of Ascendis Pharma A/S - ADR (ASND) as of Q1 2022
As of 31 Mar 2022,
Ascendis Pharma A/S - ADR (ASND) was held by
169 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,928,932 shares.
The largest 10 holders included
Artisan Partners Limited Partnership, RA CAPITAL MANAGEMENT, L.P., FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, BAKER BROS. ADVISORS LP, JANUS HENDERSON GROUP PLC, WESTFIELD CAPITAL MANAGEMENT CO LP, Avoro Capital Advisors LLC, and GOLDMAN SACHS GROUP INC.
This page lists
169
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.